Uxin (UXIN) Common Equity (2016 - 2025)
Uxin filings provide 10 years of Common Equity readings, the most recent being -$32.6 million for Q4 2025.
- On a quarterly basis, Common Equity rose 36.46% to -$32.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$32.6 million, a 36.46% increase, with the full-year FY2025 number at -$33.0 million, up 34.55% from a year prior.
- Common Equity hit -$32.6 million in Q4 2025 for Uxin, up from -$28.8 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of -$186391.0 in Q2 2023 to a low of -$28.8 billion in Q3 2025.
- Median Common Equity over the past 5 years was -$118.7 million (2023), compared with a mean of -$1.9 billion.
- Biggest five-year swings in Common Equity: skyrocketed 77.98% in 2024 and later plummeted 60385.58% in 2025.
- Uxin's Common Equity stood at -$297.8 million in 2021, then grew by 20.1% to -$237.9 million in 2022, then grew by 14.7% to -$203.0 million in 2023, then surged by 74.76% to -$51.2 million in 2024, then surged by 36.46% to -$32.6 million in 2025.
- The last three reported values for Common Equity were -$32.6 million (Q4 2025), -$28.8 billion (Q3 2025), and -$39.8 million (Q2 2025) per Business Quant data.